Abstract
Radiotherapy is involved in many curative treatments of cancer; millions of survivors live with the consequences of treatment, and toxicity in a minority limits the radiation doses that can be safely prescribed to the majority. Radiogenomics is the whole genome application of radiogenetics, which studies the influence of genetic variation on radiation response. Work in the area focuses on uncovering the underlying genetic causes of individual variation in sensitivity to radiation, which is important for effective, safe treatment. In this review, we highlight recent advances in radiotherapy and discuss results from four genome-wide studies of radiotoxicity.
Keywords
RadiogenomicsRadiation therapyHuman geneticsGenomicsGenomeMedicinePrecision medicineComputational biologyBioinformaticsBiologyGeneticsInternal medicineGene
Affiliated Institutions
Related Publications
Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment
Radiogenomics is the whole genome application of radiogenetics, which focuses on uncovering the underlying genetic causes of individual variation in sensitivity to radiation. Th...
Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study
The EORTC Radiotherapy Cooperative Group performed a prospective phase II study in glioblastoma multiforme using accelerated radiotherapy in escalating doses. The aims of the st...
Symptom Frequency and Severity in Patients with Metastatic or Locally Recurrent Lung Cancer: A Prospective Study Using the Lung Cancer Symptom Scale in a Community Hospital
Patients with advanced lung cancer suffer frequent and severe symptoms that worsen in the final months of life. The appropriate timing and combination of radiotherapy and chemot...
Accelerated Radiotherapy, Carbogen, and Nicotinamide in Glioblastoma Multiforme: Report of European Organization for Research and Treatment of Cancer Trial 22933
PURPOSE: A three-step phase I/II trial associating accelerated radiotherapy with carbogen (step 1, ARCO), with nicotinamide (step 2, ARN), or with both (step 3, ARCON) was condu...
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
A systematic review was conducted to develop guidelines for radiotherapy in adult patients with newly diagnosed malignant glioma. MEDLINE, CANCERLIT, the Cochrane Library, and r...
Publication Info
- Year
- 2011
- Type
- article
- Volume
- 3
- Issue
- 8
- Pages
- 52-52
- Citations
- 198
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
198
OpenAlex
3
Influential
164
CrossRef
Cite This
Catharine West,
Gillian C. Barnett
(2011).
Genetics and genomics of radiotherapy toxicity: towards prediction.
Genome Medicine
, 3
(8)
, 52-52.
https://doi.org/10.1186/gm268
Identifiers
- DOI
- 10.1186/gm268
- PMID
- 21861849
- PMCID
- PMC3238178